KMT2A and acute myeloid leukemia: Taken together, downregulation of SETD2 caused a strong anti-proliferative response in primary human AML cells and cell lines expressing various MLL-fusion genes, suggesting a requirement for SETD2 in the oncogenic context of MLL-fusion proteins.